Shares of Exponent, Inc. (NASDAQ:EXPO) have received an average broker rating score of 1.67 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and two have given a strong buy recommendation to the company.

Brokers have set a 1 year consensus price target of $56.00 for the company and are expecting that the company will post $0.29 earnings per share for the current quarter, according to Zacks. Zacks has also given Exponent an industry rank of 59 out of 255 based on the ratings given to related companies.

A number of research analysts recently weighed in on the stock. ValuEngine raised shares of Exponent from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 5th. Zacks Investment Research lowered shares of Exponent from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 20th. SunTrust Banks raised their price target on shares of Exponent to $56.00 and gave the company a “buy” rating in a research note on Friday, July 20th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $24.00 price target on shares of Exponent in a research note on Friday, April 20th.

In other Exponent news, insider Richard Reiss sold 2,236 shares of the firm’s stock in a transaction that occurred on Tuesday, July 31st. The shares were sold at an average price of $49.43, for a total value of $110,525.48. Following the transaction, the insider now directly owns 4,054 shares of the company’s stock, valued at approximately $200,389.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Debra Zumwalt sold 500 shares of the firm’s stock in a transaction that occurred on Friday, May 25th. The stock was sold at an average price of $96.01, for a total transaction of $48,005.00. Following the completion of the transaction, the director now directly owns 6,940 shares in the company, valued at $666,309.40. The disclosure for this sale can be found here. Company insiders own 2.70% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EXPO. BlackRock Inc. lifted its stake in Exponent by 121.0% in the 2nd quarter. BlackRock Inc. now owns 7,238,515 shares of the business services provider’s stock worth $349,620,000 after purchasing an additional 3,963,618 shares in the last quarter. Conestoga Capital Advisors LLC lifted its stake in Exponent by 111.6% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,989,839 shares of the business services provider’s stock worth $96,109,000 after purchasing an additional 1,049,534 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Exponent by 88.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,736,818 shares of the business services provider’s stock worth $83,890,000 after purchasing an additional 814,572 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Exponent by 109.9% in the 2nd quarter. Janus Henderson Group PLC now owns 1,062,498 shares of the business services provider’s stock worth $51,319,000 after purchasing an additional 556,278 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in Exponent by 88.4% in the 2nd quarter. Renaissance Technologies LLC now owns 1,099,651 shares of the business services provider’s stock worth $53,113,000 after purchasing an additional 515,851 shares in the last quarter. 49.34% of the stock is currently owned by institutional investors and hedge funds.

Shares of Exponent stock opened at $50.80 on Wednesday. The stock has a market capitalization of $2.62 billion, a P/E ratio of 47.48 and a beta of 0.59. Exponent has a twelve month low of $31.73 and a twelve month high of $52.63.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Thursday, July 19th. The business services provider reported $0.34 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.03. The firm had revenue of $95.60 million for the quarter, compared to analyst estimates of $89.42 million. Exponent had a net margin of 13.51% and a return on equity of 20.52%. Exponent’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period last year, the company posted $0.51 EPS. equities analysts anticipate that Exponent will post 1.27 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 21st. Investors of record on Friday, September 7th will be paid a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend is Thursday, September 6th. Exponent’s dividend payout ratio is presently 48.60%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Recommended Story: Penny Stocks

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.